(Q36310926)

13 August 2017

1 reference

title

Erythropoietin-induced, antibody-mediated pure red cell aplasia (English)

1 reference

13 August 2017

1 reference

Jérôme Rossert

1

1 reference

13 August 2017

Pure Red Cell Aplasia Global Scientific Advisory Board (GSAB)

series ordinal

2

1 reference

13 August 2017

publication date

1 December 2005

1 reference

European Journal of Clinical Investigation

13 August 2017

published in

1 reference

13 August 2017

volume

35 Suppl 3

1 reference

13 August 2017

page(s)

95-99

1 reference

Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01536.X

Antibodies against rHuEPO: native and recombinant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01536.X

Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01536.X

Development and evaluation of a new ELISA for the detection and quantification of antierythropoietin antibodies in human sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01536.X

Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01536.X

10.1111/J.1365-2362.2005.01536.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference